Insulin Resistance, Explained Without the Jargon

“Insulin resistance” turns up in conversations about weight, blood sugar, and metabolism so often that it can begin to sound like an explanation for everything.

It describes something specific: the body is not responding to insulin as well as it should. It can increase the risk of prediabetes and type 2 diabetes, but those terms are not interchangeable.

Understanding the difference helps you make sense of a test result—and avoid diagnosing yourself from a symptom list online.

What insulin normally does

Insulin is a hormone made by the pancreas. Among its jobs, it helps glucose move from the bloodstream into cells where it can be used for energy.

With insulin resistance, cells in tissues such as muscle, fat, and liver respond less effectively to the insulin signal. The pancreas may compensate by making more insulin. Blood glucose can remain within its usual range for a time; if the system cannot keep up, glucose levels rise.

That is why insulin resistance does not automatically mean a person already has diabetes. The NIDDK’s insulin resistance guide explains the relationship between the underlying process and higher blood glucose.

Prediabetes describes blood glucose, not a body type

Prediabetes means blood glucose is above the normal range but below the range used to diagnose diabetes. It signals increased risk, rather than a certainty that diabetes will develop.

Body weight and waist size can be part of a risk assessment, but appearance cannot tell you a blood glucose result. Family history, age, physical activity, a history of gestational diabetes, some health conditions, and certain medicines can also matter.

People with insulin resistance or prediabetes often have no symptoms. That makes claims that a particular craving, body shape, or tired afternoon proves insulin resistance unreliable.

If you are concerned, ask about your risk and whether testing is appropriate. You do not need to identify a visible sign before having that conversation.

What the usual tests actually measure

Clinicians commonly assess blood glucose using tests such as A1C or fasting plasma glucose. An oral glucose tolerance test is another option in some circumstances.

A1C reflects average blood glucose over roughly the previous three months. Fasting glucose measures the level at the time the sample is taken after the required fast. Neither is a direct measurement of how much insulin resistance a person has.

For many nonpregnant adults, an A1C from 5.7% to 6.4% falls in the prediabetes range. A result of 6.5% or above is in the diabetes range, but diagnosis generally needs confirmation when clear symptoms are absent. Conditions affecting red blood cells or hemoglobin can make A1C misleading, so a clinician needs to interpret the result in context. NIDDK A1C guidance.

Specialized testing of insulin resistance is used mainly in research. An online “optimal insulin” target should not replace an assessment of your overall health.

A useful response is broader than cutting out sugar

Food matters, but the conversation should not end with a single forbidden ingredient. Activity, sleep, weight management when appropriate, and treatment of related conditions can all be part of care.

You might begin by asking which change would be most useful and manageable for you. That could mean working on a regular eating pattern, replacing a usual sugary drink, finding an activity you can sustain, or getting help with a sleep problem. These are examples to discuss, not a prescription for every reader.

The NIDDK describes lifestyle support and, for some people, medicines such as metformin as ways to reduce diabetes risk. Its Diabetes Prevention Program overview explains the research behind prevention efforts.

You do not need to achieve an idealized routine before beginning. A plan is more useful when it accounts for your work, food access, mobility, and preferences.

Where weight-loss medicines fit

A concern about insulin resistance alone does not tell you which medicine you need. Eligibility and treatment choice depend on the diagnosis, weight-related health concerns, other medicines, and individual risks.

If GLP-1-based treatment comes up, ask what condition the clinician is treating and what improvement will be measured. Is the goal blood glucose management, weight management, or another approved use? The ingredient and brand name are not enough to answer that question.

For background, our guide to how GLP-1 weight-loss medicines work explains the treatment family.

Leave with a result you understand

If a test is abnormal, ask what it means, whether it needs confirmation, and when it should be repeated. Also ask what you can reasonably work on before the next visit.

A laboratory number is information for making a plan. It is not a verdict on your effort, and it does not tell the whole story of your health.